Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Lingling, Xuan"'
Autor:
Chang Liu, Kun Chen, Fei Zhao, Lingling Xuan, Yuting Wang, Chungui Xu, Zhiyuan Wu, Dongmei Wang, Chunfeng Qu
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-17 (2022)
Abstract Background Some occult hepatitis B virus (HBV) infections are resulted from PreS mutations that reduce secretion of envelope protein (HBsAg). We investigated the ceramide amounts and species in hepatocytes infected with PreS variants that we
Externí odkaz:
https://doaj.org/article/cac44fb3209e4d7697f637aa8a8dffad
Autor:
Lingling Xuan, Feifei Han, Lili Gong, Yali Lv, Zirui Wan, He Liu, Lulu Ren, Song Yang, Wen Zhang, Ting Li, Chunting Tan, Lihong Liu
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-9 (2020)
Abstract Background Ceramide, a bioactive lipid, plays an essential role in the development of several pulmonary inflammatory diseases. Matrix metallopeptidase 9 (MMP-9) regulates the synthesis and degradation of extracellular matrix, and is associat
Externí odkaz:
https://doaj.org/article/c8becc15318545f4a4dee3cd91bfdb2c
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Anlotinib (ANL) shows promising efficacy in patients with renal cell cancer (RCC). Here, for the first time, a serum eicosanoid metabolomics profile and pharmacodynamics in Renca syngeneic mice treated with ANL was performed and integrated using our
Externí odkaz:
https://doaj.org/article/c03b53275dd44489ac5ac3a381bdd006
Autor:
Lingling Xuan, Feifei Han, Lili Gong, Yali Lv, Zirui Wan, He Liu, Dongsu Zhang, Yangjie Jia, Song Yang, Lulu Ren, Lihong Liu
Publikováno v:
Lipids in Health and Disease, Vol 17, Iss 1, Pp 1-8 (2018)
Abstract Background Metabolic syndrome is a common extrapulmonary comorbidity in patients with chronic obstructive pulmonary disease (COPD). However, the reported relationship of COPD with dyslipidemia, an important component of metabolic syndrome, i
Externí odkaz:
https://doaj.org/article/dd4054db1cfc40fd9f81f00153d4185e
Publikováno v:
Crystal Growth & Design. 22:2407-2416
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb884d4801d815b491702845bd633f21
https://doi.org/10.1021/acs.cgd.1c01481
https://doi.org/10.1021/acs.cgd.1c01481
Autor:
Lingling Xuan, Thierry Duffar
Publikováno v:
CrystEngComm. 24:4509-4518
and kann obtained from numerical simulations of Ti:sapphire annealing experiments (left) and their applications during crystal growth (right).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5692e5a8189ea447b7e091adea36d947
https://doi.org/10.1039/d2ce00547f
https://doi.org/10.1039/d2ce00547f
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Background: Chronic inflammation is one of the important mediators of colitis-related colon cancer (CRC). Abundant mast cells (MCs) were observed in the tumor microenvironment and mediators released upon MC activation play an important role in the pr
Externí odkaz:
https://doaj.org/article/aa5a0242796b4c93a9fd97597ff54df0
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147380 (2016)
BACKGROUND:Histone deacetylase 2 (HDAC2) is a class I histone deacetylase family member that plays a critical role in suppressing inflammatory gene expression in the airways, lung parenchyma, and alveolar macrophages in patients with chronic obstruct
Externí odkaz:
https://doaj.org/article/626a52b2926a47abbea499bb68261987
Publikováno v:
Cancer Chemotherapy and Pharmacology. 87:103-112
Rate-limiting enzyme 3b-hydroxysteroid dehydrogenase type 1 (3βHSD1) encoded by HSD3B1 catalyzes the transition of dehydroepiandrosterone (DHEA) to dihydrotestosterone (DHT). The HSD3B1 (1245C) variant renders 3bHSD1 of resistant to ubiquitination a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b29a44587f2ea6217475deb824a1ba4
https://doi.org/10.1007/s00280-020-04192-z
https://doi.org/10.1007/s00280-020-04192-z
Publikováno v:
Disease Markers
Disease Markers, Vol 2020 (2020)
Disease Markers, Vol 2020 (2020)
Metabolic syndrome (MetS) is a health disorder characterized by metabolic abnormalities that predict an increased risk to develop cardiovascular disease (CVD) and type 2 diabetes. Biomarkers can provide an insight into the novel mechanism for MetS an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efa4bc36c0f750e30618943b15e26227
https://doi.org/10.1155/2020/8842320
https://doi.org/10.1155/2020/8842320